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Conclusions. These results show that transcutaneous mea-Noninvasive transcutaneous determination of access blood flow
surement of Qa is an accurate, simple, and fast technique forrate.
determining Qa without requiring the reversal of the dialysisBackground. Current indicator dilution techniques for de-
blood lines.termining the vascular access blood flow rate (Qa) require re-
versal of the dialysis blood lines and are time consuming. We
have recently described an indicator dilution technique for
determining Qa using a novel optical transcutaneous hematocrit Routine determination of the rate of blood flow within(Hct) sensor that does not require reversal of the dialysis lines,
the vascular access during maintenance hemodialysis isand have validated the accuracy of this method (TQa) in vitro.
currently considered an integral component of vascularMethods. This study compared results using the TQa method
with those obtained using a similar indicator dilution technique access assessment [1]. Although the relative importance
but which required reversal of the dialysis lines (HD01 Moni- of vascular access flow rate and venous pressure mea-
tor, Transonic Systems, Ithaca, NY, USA) during routine he- surements [2, 3] in detecting venous stenoses is still con-modialysis in 59 patients (25 native fistulas and 34 synthetic
troversial [4–6], both the magnitude [5, 7–13] and thegrafts). The sensor for the TQa method was placed on the skin
rate of decrease [14] in the vascular access flow rate havedirectly over the access to measure changes in Hct approxi-
mately 25 mm downstream of the venous needle. A single 30 been shown to predict venous thrombosis and access
mL bolus of saline was infused into the dialyzer venous line failure. The traditional approach for determining the
over approximately six seconds without reversal of the dialysis vascular access flow rate is by Doppler flow imaging [15];blood lines, and the vascular access flow rate was calculated
however, these procedures are expensive and cannot beusing indicator dilution methods from the time-dependent de-
performed during routine hemodialysis. Furthermore,crease in the Hct downstream of the venous needle. Two addi-
tional small-scale studies were performed to assess the effect the results using this approach are dependent on the
skin pigmentation and to evaluate further the reproducibility machine [16] and operator.
of the TQa method. The vascular access flow rate can also be accurately
Results. Qa values determined by the TQa method were determined using indicator dilution methods. Early indi-highly correlated with those determined by the HD01 method
cator dilution studies measured the vascular access flow(N  72, R2  0.948, P  0.001) over the range of 153 to 2,042
rate by injecting cardiogreen [17] or radiolabeled [18–20]mL/min. There was no significant difference between vascular
access flow rates determined by the TQa method and those substances at a constant rate into the arterial end of the
determined by the HD01 method. Results from one small- access, and calculated the vascular access flow rate from
scale study showed that the relationship between Qa values the steady-state downstream concentration of the in-determined by the TQa and the HD01 methods was similar
jected substance. These early attempts to use indicatorwhen tested only among black patients (N  12), suggesting
dilution methods were limited to research applicationsthat skin pigmentation is not an important determinant of the
accuracy of the TQa method. The second small-scale study since this approach could not be routinely performed
showed that the intratreatment coefficient of variation for the during clinical hemodialysis. To determine the vascular
TQa method was 7.8  5.6% (N  14). access flow rate during the hemodialysis procedure, Kriv-
itski and Depner showed how reversal of the dialysis
blood lines (switching the arterial and venous connec-Key words: hematocrit, indicator dilution, vascular access, Qa, dialysis,
maintenance hemodialysis, optical Hct scanner. tions) would direct the blood flow within the hemodialy-
sis circuit to facilitate the injection of an indicator in theReceived for publication August 2, 2000
arterial end of the access and its detection downstreamand in revised form December 14, 2000
Accepted for publication January 19, 2001 [21–23]. Various modifications of this approach subse-
quently have been developed [8, 24–27]. While these 2001 by the International Society of Nephrology
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Fig. 1. Cross-sectional illustration of the photo-
optical sensor used in the transcutaneous blood
flow rate (TQa) method. A light-emitting diode
(LED) and photodiode (or photodetector)
components of the transcutaneous Hct sensor
placed on the skin directly over the access.
The volume of tissue illuminated by the LED
illustrates the reflective penetration of the
photons () as seen by the photodetectors in
the process of determination of the Hct, which
incorporates the access site and the photon
propagation in the tissue volume not con-
taining the access (0). Details are in the text.
indicator dilution methods permit determination of the are mathematically expressed in terms of a bulk attenua-
tion coefficient (), which is specific to the illuminatedvascular access flow rate during routine hemodialysis,
reversal of the dialysis blood lines from their normal media. The amount of light detected by the photodetec-
tor is proportional via a modified Beer’s law formula toconfiguration is inconvenient and time consuming, since
it requires that the dialyzer blood pump be stopped and the instantaneous net  value of the media [28]. The
mathematical details describing the relationship betweenthe dialysis lines disconnected. Furthermore, some of
these indicator dilution methods also require accurate the intensity of light detected by the photodetector and
the Hct are shown in Appendix 1.determination of the dialyzer blood flow rate.
We have developed an optical hematocrit (Hct) sensor When the volume of tissue illuminated includes all or
even part of the access, the resultant  value includesthat can detect changes in Hct transcutaneously and have
shown how such a sensor could be used to determine the information about both the surrounding tissue and the
access itself. In order to resolve the signal due to bloodvascular access flow rate without reversal of the dialysis
blood lines in an in vitro model hemodialysis circuit flowing within the access from that due to the surrounding
tissues, the sensor system illuminates adjacent tissue re-(abstract; Steuer et al, J Am Soc Nephrol 11:198A, 2000).
Our current study evaluated the accuracy and variability gions on either side of the access (Fig. 1). Values of 0
for tissue regions not containing the access are then usedof this new approach for determining the vascular access
to normalize the signal, thus providing a baseline fromflow rate during routine hemodialysis.
which relative changes in access Hct can be assessed.
METHODS Indicator dilution method
Sensor description Figure 2 illustrates blood flow through a hemodialysis
vascular access with the dialysis blood lines in the normalThe optical sensor system consists of a light-emitting
configuration and the key features of the current (TQa)source (an LED of specific wavelength) and a comple-
method. The transcutaneous Hct sensor is placed directlymentary photodetector. In this application, a wavelength
over the vascular access downstream of the venous dial-of 880 nm was used because it is near the known isobestic
ysis needle. The sensor and associated monitoring systemwavelength for hemoglobin, is commercially available,
continuously records a signal proportional to the Hctand has been shown to be effective in the optical determi-
from which the relative change in Hct in the vascularnation of whole blood parameters such as Hct and oxy-
access can be accurately determined (Appendix 1). Aftergen saturation [28].
a stable baseline value (proportional to the Hct in theWhen the sensor is placed on the surface of the skin,
access or Ha) is obtained, a known volume (V) of normalthe LED illuminates a volume of tissue, and a small
saline is injected via a syringe into the dialysis venousfraction of the light absorbed and backscattered by the
line that reduces the Hct beneath the sensor H(t) duringmedia is detected by the photodetector, as shown in
and immediately following the injection. The vascularthe cross-sectional diagram of Figure 1 [29]. While light
access flow rate (Qa) can be calculated using bolus injec-travels in a straight line, the illuminated volume as seen
tion, indicator dilution principles [30] from the followingby the photodetector may be visualized as an isointensity
equation (Appendix 2):ellipsoid, as individual photons of light are continuously
scattered and absorbed by the media (Fig. 1). Since a
Qa  V/H(t)/Hadt (Eq. 1)wavelength of 880 nm was chosen, hemoglobin of the
blood within the tissue volume is the principal absorbing where H(t) denotes Ha  H(t), and the integral (area
under the curve) in this equation is from the time ofsubstance. The scattering and absorbing characteristics
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configuration, and the dialyzer blood pump was re-
started. The transcutaneous Hct sensor was placed on
the skin over the patient’s vascular access approximately
25 mm downstream of the venous needle. Thirty milli-
liters of normal saline solution were then injected into
the venous needle at a rate of approximately 300 mL/
min to determine vascular access blood flow rate by the
TQa method. In six patients, saline was injected directly
into the arterial dialysis needle before connecting the
needle to the complete dialysis circuit. In two patients,
saline was injected directly into the access by using a
needle and syringe. The data from these various methods
were combined together, independent of where saline
was injected into the access. In 38 patients, this measure-
ment was performed in duplicate to assess the replicabil-
ity of this method.
Two additional small-scale studies were performed to
assess the effect of skin pigmentation and to evaluate
Fig. 2. Schematic diagram of the hemodialysis circuit. The injection the reproducibility of the TQa method further. In one of
(syringe) and measurement sites (TQa Hct sensor) are indicated. The these studies, 12 additional black patients were evaluated
Hcts and flow rates under steady-state conditions are also indicated.
using the protocol described previously in this article,Abbreviations are: Qa, access flow rate; Qb, dialyzer blood flow rat; Qi,
injection flow rate; Ha, Hct in the access flow; Ho, Hct at the sensor. and vascular access flow rates determined by the TQa
and HD01 methods were compared. In the second small-
scale study, the vascular access blood flow rate was deter-
mined twice in 14 patients during the same hemodialysis
injection (t  0) to where the signal has returned to the session after the sensor had been removed and reposi-
baseline value (t∞). This equation is valid independent tioned on the skin surface. In both of these latter studies,
of the rate of saline injection or the dialyzer blood flow the saline bolus was always injected into the arterial
rate. dialysis needle when determining vascular access flow
rate by the TQa method.In vivo studies
The 59 patients initially studied were recruited from Statistics
four different dialysis units (Bonneville Dialysis Unit, All measured and calculated values are reported as
Ogden, UT, USA; Taylorsville Dialysis Unit, Taylorsville, mean SD. The significance of differences in calculated
UT, USA; Central Valley Dialysis Unit, Salt Lake City, vascular access flow rates by the TQa method and those
UT, USA; and Southeastern Wyoming Dialysis Center, by the HD01 method was determined using a paired
Cheyenne, WY, USA). Prior to the study dialysis session, Student t test. The variability of the slope and intercept
a disposable tubing with an injection port (CO-daptoR; from the regression equation is expressed as  the esti-
Transonic Systems, Ithaca, NY, USA) was placed be- mated SD (or the estimated SE). The results from the
tween the venous dialysis tubing and the venous needle. replicability and reproducibility studies are expressed as
The dialysis circuit was primed with saline in the usual the mean  SD coefficient of variation for the duplicate
fashion taking extra care to remove any air bubbles from measurements. P values of less than 0.05 were considered
the venous injection port. statistically significant.
Within the first hour of dialysis, access recirculation
was first measured by the HD01 monitor (Transonic Sys-
RESULTStems). Then the dialyzer blood pump was stopped. The
dialysis lines were reversed from their normal configura- The characteristics of the patients initially studied are
tion, and the vascular access flow rate was determined shown in Table 1, and the characteristics of the accesses
in duplicate by the HD01 method. During these tests, studied are shown in Table 2 (N  59). The patients
injection of saline was performed using the saline release studied were predominantly male and white. Although
method (abstract; Krivitski et al, J Am Soc Nephrol 8: the distribution of race in our study is not representative
164A, 1997). The dialyzer blood pump was again stopped, of that within the United States as a whole, it is represen-
and the dialysis lines were returned to their normal con- tative of the population in this geographic region. The
figuration. age of the patients, the fraction of diabetic patients, and
the fraction of patients with synthetic polytetrafluoro-After dialysis, blood lines were returned to the normal
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Table 2. Access characteristics (N  59)Table 1. Patient characteristics (N  59)
Characteristic Value Characteristic Frequency
PTFE grafts 34/59 (57.6%)Age years 6515
Male 42/59 (71.2%) Access location
Upper arm 22/59 (37.3%)Diabetic 28/59 (47.5%)
Race Lower arm 35/59 (59.3%)
Leg 2/59 (3.3%)White 42/59 (71.2%)
Black 5/59 (8.5%) PTFE is polytetrafluoroethylene.
American Indian 1/59 (1.7%)
Asian 1/59 (1.7%)
Hispanic 10/59 (16.9%)
Data are frequency or mean  SD.
in a separate group of 12 additional black patients [3
native arteriovenous (AV) fistulas and 9 PTFE grafts].
There was no significant difference between vascular
access flow rates determined by the TQa method (861 ethylene (PTFE) grafts were similar to those for chronic
hemodialysis patients in the United States. Eleven of 164 mL/min) and those determined by the HD01 method
(830  218 mL/min), and the best fit linear-regressionthese patients were studied twice, and one patient was
studied three times; all other patients were studied once line of these data also had a slope not different from
unity and a small y intercept. The equation of this linefor a total of 72 measurements. Access recirculation was
significant in three patients. In these patients, the blood was Y  1.16 (0.21)  X  169 (180) mL/min, R2 
0.761. The absolute difference in measured vascular ac-pump setting was reduced to 150 mL/min to eliminate
access recirculation before completing the study protocol. cess flow rates between the TQa and HD01 methods in
this study was 92 62 mL/min. To compare these resultsFigure 3 shows an example plot of the function de-
scribed in Appendix 1 that is proportional to the time with those in the initial study, the data are also plotted
rate of change of Hct and is measured by the sensor when in Figure 5. No systematic differences in the results from
using the TQa method. Since the function is dependent on these two studies are obvious.
the time rate of change in Hct, its value is steady at zero The coefficient of variation described previously in this
until the injection of saline has begun. Approximately article may not accurately reflect the true reproducibility
five seconds after the injection, the value of this function of the TQa method, since the sensor remained in the same
increases and then decreases after a time period propor- position on the skin during both measurements. An addi-
tional to the length of the injection. This measured func- tional small-scale study was therefore performed in 14
tion was then integrated over the length of the injection to patients (11 white and 3 black; 2 native AV fistula and
determine the vascular access flow rate using Equation 1. 12 PTFE grafts) to determine the true reproducibility of
Figure 4 shows values of the vascular access flow rate the TQa method after the sensor had been removed from
determined by the TQa method plotted versus those de- and repositioned on the skin. The results from this study
termined by the HD01 method in this initial patient showed that the first vascular access blood flow rate
group. The best fit linear-regression line had a slope of measurement (545 245 mL/min) was not different from
essentially unity and a small y intercept, and there was the second (552  242 mL/min). The intratreatment co-
no significant difference between vascular access flow efficient of variation for this evaluation was 7.8  5.6%.
rates determined by the TQa method and those deter-
mined by the HD01 method. Figure 5 shows these same
DISCUSSIONresults plotted using an alternative approach to assess
In order to use indicator dilution techniques to mea-the agreement between two methods of clinical measure-
sure the vascular access flow rate during hemodialysis,ment [31]. The agreement between these methods was
the indicator must be injected upstream and its concen-excellent; the absolute difference in measured vascular
tration detected downstream in the blood flowing throughaccess flow rates between the TQa and HD01 methods
the vascular access. Reversing the dialysis blood lineswas 71  62 mL/min. When these results were further
during the hemodialysis treatment permits applicationanalyzed for various patient subgroups (male vs. female,
of indicator dilution principles by direct injection of thediabetic vs. nondiabetic, synthetic grafts vs. native fistu-
indicator into the venous dialysis tubing. However, thelas), excellent agreement between the measured flow
approach described in this study (TQa method) permitsrates was similarly observed. The mean intratreatment
a unique application of indicator dilution principles, sincecoefficient of variation for the TQa method was 10.5 
the sensor can detect a dilution signal downstream of the6.8%, and that for the HD01 method was 8.9  9.5%;
venous needle through the skin. This geometry permitsthese differences were not statistically significant.
determination of the vascular access flow rate withoutThe number of black patients in the previously men-
tioned study was small; thus, this protocol was repeated reversal of the dialysis blood lines, thereby maintaining
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Fig. 3. Function F(i, di/dt) measured by the
transcutaneous sensor plotted as a function of
time during one experiment. The area under
this curve is computed to calculate the vascu-
lar access flow rate using Equation 1.
Fig. 4. Vascular access flow rates (Qa) deter-
mined by the TQa method compared with
those determined by the saline dilution method
(HD01 monitor; Transonics). The line indi-
cated is that obtained by best fit linear regres-
sion. The equation of this line is Y  0.953
(0.27)  X  36 (22) mL/min.
optimal dialysis efficiency throughout the entire treat- nephrologists because it is also possible to determine
the vascular access flow rate when the patient is in thement.
The current approach is related to several previous physician’s office or in the clinic, instead of during hemo-
dialysis, by injecting saline solution directly into the ac-attempts to determine the vascular access flow rate by
injecting various indicators at a constant rate into the cess and measuring changes in transcutaneous Hct with
the optical sensor. During the initial study, eight patientsarterial end of the access to calculate the vascular access
flow rate from the steady-state downstream indicator con- had vascular access flow rate determinations by direct
injection of saline into the access prior to dialysis; theircentration [17–20]. These early approaches were limited
to the constant infusion indicator dilution approach as results were later confirmed once the dialysis circuit was
in place. Furthermore, the two additional studies werethe indicator concentration was measured in discrete
blood samples (Stewart Principle [30]). The TQa method also performed exclusively with this alternative method
for injecting saline into the access with excellent results.described herein permits the use of the bolus injection,
indicator dilution approach since the described optical Thus, it may now be possible to monitor the vascular
access flow rate regularly as an indicator of access func-sensor can accurately determine instantaneous changes
in Hct (Henriques-Hamilton-Bergner Principle [30]). This tion when the patient is not being dialyzed as well as
during maturation of native fistulas prior to first use.optical approach is likely to be of considerable interest to
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Fig. 5. Access blood flow rates (Qa) deter-
mined by the TQa method compared with
those determined by the saline dilution method
(HD01 monitor; Transonics) using a Bland-
Altman plot [31]. Symbols are: () results
from the initial study; () results from the
additional study of only black patients.
The accuracy of the TQa method depends critically on nature of these measurements suggests that the sensitiv-
at least two factors. As can be seen in Equation 1, the ity of the calculated vascular access flow rate to skin
calculated vascular access flow rate depends directly on melanin content is minimal. Our observations on black
the volume of saline injected; therefore, care must be patients suggest that skin pigmentation is not a major
taken to inject a given amount of saline over a specified concern.
time interval. The time interval for injection does not We conclude that transcutaneous measurement of Qa
need to be known precisely; however, it is important is an accurate, simple, and fast technique for determining
that it be less than approximately 10 seconds to avoid Qa without reversal of the dialysis blood lines. Further
significant interference caused by cardiopulmonary recir- studies to determine the potential importance of other
culation of the injected saline solution. The second factor clinical parameters (such as patient obesity and collateral
that is important to consider in the accuracy of the TQa circulation in fistulas) on the accuracy of this method
method is the placement of the sensor to determine accu- and to document the usefulness of this new method for
rately changes in Hct through the skin. The sensor must diagnosis of stenosis, thrombosis, and failure of the vas-
be placed directly over the vascular access site in the cular access during routine hemodialysis are warranted.
specified orientation to determine relative changes in
Hct accurately. Additional variability caused by sensor ACKNOWLEDGMENTS
placement does not appear to be significant, however.
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large accesses or with deep accesses such as those found
in the upper arm or thigh (abstract; Steuer et al, J Am
APPENDIX 1Soc Nephrol 11:198A, 2000). Less accurate results would
In biological tissues, where there is simultaneous absorption andalso be obtained if the sensor did not accurately detect
scattering of light, the intensity of light detected at a photodetectorchanges in Hct due to significant variation in skin pig-
(i) is related to the light emitted (i0) by a complex function of the
mentation. It should be noted that the TQa sensor has optical properties of the tissue [32]. We assume that this relationship
can be expressed over small changes in Hct by the following equationbeen specifically designed to account for the individual
[29, 33]:absorption and scattering properties of patient tissues
(discussed previously in this article), and the normalized i  i0 ·  · exp( · d) (Eq. A1.1)
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where  and d denote the bulk attenuation coefficient and the distance 2% in vascular access blood flow rate when calculated using Equation
1 of the main text.between the light source and detector, respectively. For an optical
sensor placed on the skin, the bulk attenuation coefficient is a complex
function of the attenuation and scattering coefficients of the various REFERENCESlayers of tissue (epidermis, dermis, and subcutaneous tissue) [28, 34].
For systems in which light-scattering dominates light absorption within 1. Schwab S, Besarab A, Beathard G, et al: NKF-DOQI clinical
the tissue, the bulk attenuation coefficient can be approximated by practice guidelines for vascular access. Am J Kidney Dis 30(Suppl
the following equation (Steuer et al, unpublished observations): 3):S150–S189, 1997
2. Schwab SJ, Raymond JR, Saeed M, et al: Prevention of hemodialy-
  (	 · H  20)1/2 (Eq. A1.2) sis fistula thrombosis: Early detection of venous stenosis. Kidney
Int 36:707–711, 1989where 	 and 0 denote a proportionality constant and the time-indepen-
3. Besarab A, Sullivan KL, Ross RP, Moritz MJ: Utility of intra-dent background attenuation coefficient, respectively.
access pressure monitoring in detecting and correcting venous out-Differentiating Equation A.1.1 with respect to time and normalizing
let stenosis prior to thrombosis. Kidney Int 47:1364–1373, 1995by the intensity of detected light yields the time-dependent change in
4. Blankestijn PJ, Smits JHM: How to identify the haemodialysislight detected by the photodetector as:
access at risk of thrombosis? Are flow measurements the answer?
Nephrol Dial Transplant 14:1068–1071, 19991
i
di
dt
 
1
d 
1

	
2
dH
dt
(Eq. A1.3) 5. Paulson WD, Ram SJ, Birk CG, Work J: Does blood flow accu-
rately predict thrombosis or failure of hemodialysis synthetic
Dividing both sides of Equation A.1.3 by (2  02)  	H (Eq. grafts? A meta-analysis. Am J Kidney Dis 34:478–485, 1999
1.2) provides an expression for (1/H)(dH/dt) and eliminates the need 6. Paulson WD, Ram SJ, Birk CG, et al: Accuracy of decrease in
for determining the factor 	: blood flow in predicting hemodialysis graft thrombosis. Am J Kid-
ney Dis 35:1089–1095, 2000
7. Strauch BS, O’Connell RS, Geoly KL, et al: Forecasting throm- 12  20
1
i
di
dt
 
1
2d 
1

1
H
dH
dt
(Eq. A1.4)
bosis of vascular access with Doppler color flow imaging. Am J
Kidney Dis 19:554–557, 1992
Experimental determination of both the intensity of detected light 8. Lindsay RM, Blake PG, Malek P, et al: Hemodialysis access
and its time derivative permits the evaluation of the following function blood flow rates can be measured by a differential conductivity
defined as F(i,di/dt): technique and are predictive of access clotting. Am J Kidney Dis
30:475–482, 1997
F i, didt 
1
i
di
dt


(d  1/)(2  20)
(Eq. A1.5) 9. May RE, Himmelfarb J, Yenicesu M, et al: Predictive measures
of vascular access thrombosis: A prospective study. Kidney Int
52:1656–1662, 1997This function is dependent only on the fractional change in Hct
10. Bosman PJ, Boereboom FTJ, Eikelboom BC, et al: Graft flowand can be used to determine the vascular access flow rate by substitu-
as a predictor of thrombosis in hemodialysis grafts. Kidney Inttion into Equation 1 of the main text.
54:1726–1730, 1998
11. Bay BH, Henry MI, Lazarus JM, et al: Predicting hemodialysis
access failure with color flow Doppler ultrasound. Am J Nephrol
APPENDIX 2 18:296–304, 1998
12. Miranda CL, Sands JJ: Flow volumes as a predictor of hemodialy-
Derivation of an equation to calculate the vascular access flow rate sis access failure. J Vasc Technol 22:73–76, 1998
when using the bolus injection, indicator dilution approach is complex. 13. Wang E, Schneditz D, Nepomuceno C, et al: Predictive value
Perl has shown, however, that the constant infusion and bolus injection of access blood flow in detecting access thrombosis. ASAIO J
indicator dilution approaches yield identical results [35]; therefore, 44:M555–M558, 1998
we derive below the governing equation from steady-state constant 14. Neyra NR, Ikizler TA, May RE, et al: Change in access blood
infusion principles [30]. Consider the dialysis circuit in Figure 2, where flow over time predicts vascular access thrombosis. Kidney Int
a steady infusion of saline solution occurs in the dialysis venous blood 54:1714–1719, 1998
line (ultrafiltration at the dialyzer is neglected). We further assume 15. Sands J: The role of color-flow Doppler ultrasound in the manage-
that the outflow resistance at the venous side of the vascular access is ment of hemodialysis accesses. ASAIO J 44:41–43, 1998
large; therefore, the injected saline will slow the flow in between the 16. Winkler A, Wuj A, Case T, Ricci M: An experimental study of
arterial and venous needles. Red blood cell balance where the dialysis the accuracy of flow measurements using commercial ultrasound
venous blood flow enters the access requires: systems. J Vasc Technol 19:175–180, 1995
17. Kult VJ, Scheitza E, Grosswendt J, Klu¨tsch K: Das reale shunt-Ha(Qa  Qb  Qi)  HaQb  Ho(Qa) (Eq. A2.1) volumen subkutaner arterioveno¨ser fisteln bei chronisch ha¨modia-
lysierten patienten. Z Kardiol 62:158–164, 1973Solving for Qa yields:
18. Gottlieb S, Garcia E, Cold SB, Vanderwerf BA: Radiotracer
Qa  Qi/H/Ha (Eq. A2.2) method for nonsurgical measurement of blood flow in bovine graft
arteriovenous fistulas. Proc Dial Transplant Forum 6:107–108, 1976
where H denotes Ha  Ho. This equation describes the relationship 19. Kaye M, Lamaitre P, O’Regan S: A new technique for measuring
between the vascular access flow rate and relative changes in Hct at blood flow in polytetrafluorethylene grafts for hemodialysis. Clin
the sensor during a constant infusion of normal saline in the venous Nephrol 8:533–534, 1977
dialysis blood line. (If ultrafiltration at the dialyzer occurs at a rate of 20. O’Regan S, Lemaitre P, Kaye M: Hemodynamic studies in patients
Qf, then the numerator in this equation becomes Qi Qf.) Noting that with expanded polytetrafluoroethylene (PTFE) forearm grafts.
Qi is equivalent to the volume of saline injected in a specified time Clin Nephrol 10:96–100, 1978
interval, Equation 2A reduces to Equation 1 in the Methods section 21. Krivitski NM: Theory and validation of access flow measurement
during the bolus injection, indicator dilution approach [30, 35]. by dilution technique during hemodialysis. Kidney Int 48:244–250,
It should be noted that the previously mentioned equations do not 1995
apply if a significant stenosis exists between the dialysis needles such 22. Krivitski NM: Novel method to measure access flow during hemo-
that the outflow resistance is less than the flow resistance upstream. dialysis by ultrasound velocity dilution technique. ASAIO J
In this case, the injected saline will increase the flow on the venous 41:M741–M745, 1995
side of the access, thereby increasing the vascular access flow rate 23. Depner TA, Krivitski NM: Clinical measurement of blood flow
under the sensor. Nevertheless, this condition does not cause substan- in hemodialysis access fistulae and grafts by ultrasound dilution.
ASAIO J 41:M745–M749, 1995tial changes to the analysis and is expected to produce errors less than
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24. Schneditz D, Fan Z, Kaufman A, Levin NW: Measurement of 30. Lassen NA, Henriksen O, Sejrsen P: Indicator methods for mea-
surement of organ and tissue blood flow, in Handbook of Physiol-access flow during hemodialysis using the constant infusion ap-
ogy (section 2): The Cardiovascular System (vol III), edited byproach. ASAIO J 44:74–81, 1998
Shepherd JT, Abboud FM, Bethesda, American Physiological So-25. Yarar D, Cheung AK, Sakiewicz P, et al: Ultrafiltration method
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